PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Aug-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
18-Aug-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
18-Aug-2022 CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update CureVac
18-Aug-2022 CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate CureVac
18-Aug-2022 Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA) Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
18-Aug-2022 ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing ProBioGen
18-Aug-2022 NICE Recommends RINVOQ®▼(upadacitinib) As A Treatment Option For Active Ankylosing Spondylitis (AS) In Adults AbbVie
18-Aug-2022 Sanofi provides update on amcenestrant clinical development program Sanofi
18-Aug-2022 Orgenesis Achieves Revenue of USD 7.2 Million for the Second Quarter of 2022 Orgenesis
18-Aug-2022 Zur Rose Group speeds up path to profitability and plans break-even at EBITDA level in 2023 Zur Rose Group AG
17-Aug-2022 Douglas GmbH: Release of results for the third quarter and nine months 2021/22 (ending 30 June 2022) on 23 August 2022 Douglas GmbH
17-Aug-2022 ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing B3C newswire
17-Aug-2022 M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate M1 Kliniken AG
17-Aug-2022 HAEMATO AG publishes figures for Q2 2022: increase in revenues and EBIT compared to the previous quarter; confirmation of guidance for the full year 2022 HAEMATO AG
17-Aug-2022 Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source Gerresheimer AG
17-Aug-2022 Defence Therapeutics Inc.:  BREAKTHROUGH DISCOVERY: DEFENCE’S ACCUMTM VARIANT 'A1' CONVERTS MESENCHYMAL STROMAL CELLS INTO POTENT ANTIGEN PRESENTING CELLS SUITABLE FOR CANCER VACCINATION Defence Therapeutics Inc.
17-Aug-2022 Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access Relief Therapeutics Holding SA
16-Aug-2022 Abivax announces a change in its governance ABIVAX
16-Aug-2022 New BioPure Braided Hose assemblies offer a total solution for bulk fluid transfer in critical bioprocess fluid transfer applications Sciad Newswire
16-Aug-2022 IQVIA Wins Snowflake’s “Marketplace Healthcare and Life Sciences Partner of the Year” Award IQVIA